In addition, breast cancer cells secrete tumor-derived microparticles containing high levels of PD-L1 after radiotherapy, which inhibits the activity of cytotoxic T lymphocytes (CTLs) and promotes tumor growth in vitro and in vivo [55]. The gene discussed is CD274; the disease is breast carcinoma.